Oncology Nursing Update
Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:46:28
- More information
Informações:
Synopsis
Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma. CME information and select publications here
